A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy
Crossref DOI link: https://doi.org/10.1007/s12402-016-0198-1
Published Online: 2016-05-03
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sohn, Minji
Talbert, Jeffery
Moga, Daniela C.
Blumenschein, Karen
Text and Data Mining valid from 2016-05-03